| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-15 17:07:18 UTC |
|---|
| Update Date | 2021-09-14 14:59:04 UTC |
|---|
| HMDB ID | HMDB0060582 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Benazeprilat |
|---|
| Description | Benazeprilat, also known as benazepril diacid or CGS 14831, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Benazeprilat is a very strong basic compound (based on its pKa). Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor. In humans, benazeprilat is involved in benazepril metabolism pathway. Benazeprilat is a metabolite of benazepril. Benazepril, brand name Lotensin, is a medication used to treat high blood pressure, congestive heart failure, and chronic renal failure. |
|---|
| Structure | OC(=O)CN1C2=CC=CC=C2CC[C@H](N[C@@H](CCC2=CC=CC=C2)C(O)=O)C1=O InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (3S)-3-(((1S)-1-Carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid | ChEBI | | Benazepril diacid | ChEBI | | Benazeprilate | ChEBI | | Benazeprilatum | ChEBI | | CGS 14831 | ChEBI | | (3S)-3-(((1S)-1-Carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetate | Generator | | Benazeprilic acid | Generator | | Benezaprilat | HMDB |
|
|---|
| Chemical Formula | C22H24N2O5 |
|---|
| Average Molecular Weight | 396.4364 |
|---|
| Monoisotopic Molecular Weight | 396.168521888 |
|---|
| IUPAC Name | (2S)-2-{[(3S)-1-(carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino}-4-phenylbutanoic acid |
|---|
| Traditional Name | benazeprilat |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC(=O)CN1C2=CC=CC=C2CC[C@H](N[C@@H](CCC2=CC=CC=C2)C(O)=O)C1=O |
|---|
| InChI Identifier | InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1 |
|---|
| InChI Key | MADRIHWFJGRSBP-ROUUACIJSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Benzazepine
- Alpha-amino acid
- Alpha-amino acid or derivatives
- L-alpha-amino acid
- Azepine
- Aralkylamine
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Tertiary carboxylic acid amide
- Amino acid
- Amino acid or derivatives
- Lactam
- Carboxamide group
- Organoheterocyclic compound
- Azacycle
- Secondary amine
- Secondary aliphatic amine
- Carboxylic acid
- Hydrocarbon derivative
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Organic oxide
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.26 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.0619 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.71 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1637.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 216.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 168.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 112.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 415.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 431.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 148.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 964.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 481.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1384.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 287.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 304.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 283.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 151.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 80.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Benazeprilat,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N[C@@H](CCC2=CC=CC=C2)C(=O)O)CCC2=CC=CC=C21 | 3294.0 | Semi standard non polar | 33892256 | | Benazeprilat,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O | 3248.1 | Semi standard non polar | 33892256 | | Benazeprilat,1TMS,isomer #3 | C[Si](C)(C)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O | 3337.1 | Semi standard non polar | 33892256 | | Benazeprilat,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N[C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C)CCC2=CC=CC=C21 | 3189.0 | Semi standard non polar | 33892256 | | Benazeprilat,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O)[Si](C)(C)C)CCC2=CC=CC=C21 | 3252.2 | Semi standard non polar | 33892256 | | Benazeprilat,2TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CCC1=CC=CC=C1)N([C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O)[Si](C)(C)C | 3255.8 | Semi standard non polar | 33892256 | | Benazeprilat,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)CCC2=CC=CC=C21 | 3230.4 | Semi standard non polar | 33892256 | | Benazeprilat,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)CCC2=CC=CC=C21 | 3195.5 | Standard non polar | 33892256 | | Benazeprilat,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)CCC2=CC=CC=C21 | 4053.5 | Standard polar | 33892256 | | Benazeprilat,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N[C@@H](CCC2=CC=CC=C2)C(=O)O)CCC2=CC=CC=C21 | 3561.2 | Semi standard non polar | 33892256 | | Benazeprilat,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O | 3516.5 | Semi standard non polar | 33892256 | | Benazeprilat,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N([C@@H](CCC1=CC=CC=C1)C(=O)O)[C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O | 3557.4 | Semi standard non polar | 33892256 | | Benazeprilat,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N[C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C(C)(C)C)CCC2=CC=CC=C21 | 3667.4 | Semi standard non polar | 33892256 | | Benazeprilat,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O)[Si](C)(C)C(C)(C)C)CCC2=CC=CC=C21 | 3737.6 | Semi standard non polar | 33892256 | | Benazeprilat,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC1=CC=CC=C1)N([C@H]1CCC2=CC=CC=C2N(CC(=O)O)C1=O)[Si](C)(C)C(C)(C)C | 3719.5 | Semi standard non polar | 33892256 | | Benazeprilat,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CCC2=CC=CC=C21 | 3904.3 | Semi standard non polar | 33892256 | | Benazeprilat,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CCC2=CC=CC=C21 | 3800.5 | Standard non polar | 33892256 | | Benazeprilat,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN1C(=O)[C@@H](N([C@@H](CCC2=CC=CC=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CCC2=CC=CC=C21 | 4189.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Benazeprilat GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f6x-5339000000-79f0d1358b75a224dae5 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Benazeprilat GC-MS (2 TMS) - 70eV, Positive | splash10-00di-4101910000-8b1339e1a13e7ad42249 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Benazeprilat GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 10V, Positive-QTOF | splash10-0f92-0009000000-d1319ee37edec27e1148 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 20V, Positive-QTOF | splash10-0zfr-3229000000-0dc516b7bcc139e1a83d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 40V, Positive-QTOF | splash10-0apl-3921000000-0762176b089f4d89288b | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 10V, Negative-QTOF | splash10-0f6t-0009000000-0cfaafdb759ca6c4922f | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 20V, Negative-QTOF | splash10-0f9t-0129000000-fcbfafbc2f2114ad0a1f | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 40V, Negative-QTOF | splash10-0629-2911000000-7200a52de7d82e2d1856 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 10V, Positive-QTOF | splash10-0f6t-0009000000-10c2002d627e732a820c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 20V, Positive-QTOF | splash10-1000-0709000000-a5b9f077616bf86c3dc4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 40V, Positive-QTOF | splash10-01bc-1911000000-7820a2391cb1f258a53e | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 10V, Negative-QTOF | splash10-0002-0009000000-3efd2767e682bcb02a2c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 20V, Negative-QTOF | splash10-0zfs-0319000000-109ed32b6122065eadce | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benazeprilat 40V, Negative-QTOF | splash10-05fu-2920000000-8250905e19b220ccd554 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|